ScholarIQanswers from OpenAlex
Michigan Cancer Research Consortium
InstitutionResearch output, impact & collaborations
Michigan Cancer Research Consortium is a institution indexed in ScholarIQ from OpenAlex.
What is known about Michigan Cancer Research Consortium?
ScholarIQrecord summary
Michigan Cancer Research Consortium is a research organisation in Ann Arbor, US. OpenAlex records 1,137 works and 122,584 citations for it. 394 researchers list it as their most recent affiliation.
How many works does Michigan Cancer Research Consortium have?
ScholarIQindexed works
Michigan Cancer Research Consortium has 1,137 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Michigan Cancer Research Consortium have?
ScholarIQcitation count
Michigan Cancer Research Consortium has 122,584 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Michigan Cancer Research Consortium?
ScholarIQresearcher count
Michigan Cancer Research Consortium has 394 researchers in the ScholarIQ index.
What is the average h-index at Michigan Cancer Research Consortium?
ScholarIQavg h-index
Michigan Cancer Research Consortium has an average h-index of 42 in OpenAlex.
What is the ROR of Michigan Cancer Research Consortium?
ScholarIQror
The ROR for Michigan Cancer Research Consortium is on the source record.
What is the OpenAlex record for Michigan Cancer Research Consortium?
ScholarIQopenalex
The OpenAlex for Michigan Cancer Research Consortium is on the source record.
Who are the most-cited researchers behind Michigan Cancer Research Consortium?
ScholarIQtop researchers by citations
What are the most-cited papers on Michigan Cancer Research Consortium?
ScholarIQmost cited works
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
Mark B. Faries, John F. Thompson, Alistair J. Cochran, Robert H.I. Andtbacka, Nicola Mozzillo, Jonathan S. Zager, Tiina Jahkola, Tawnya L. Bowles, Alessandro Testori, Peter D. Beitsch, Harald J. Hoekstra, Marc Moncrieff, Christian Ingvar, Michel W.J.M. Wouters, Michael S. Sabel, Edward A. Levine, Doreen M. Agnese, Michael A. Henderson, Reinhard Dummer, Carlo Riccardo Rossi, Rogerio I. Neves, Steven D. Trocha, Frances C. Wright, David R. Byrd, Maurice Matter, Eddy C. Hsueh, Alastair D. MacKenzie Ross, Douglas B. Johnson, Patrick Terheyden, Adam C. Berger, Tara L. Huston, Jeffrey D. Wayne, B. Mark Smithers, Heather B. Neuman, Schlomo Schneebaum, Jeffrey E. Gershenwald, Charlotte E. Ariyan, Darius C. Desai, Lisa K. Jacobs, Kelly M. McMasters, Anja Gesierich, Peter Hersey, Steven D. Bines, John M. Kane, Richard J. Barth, Gregory McKinnon, Jeffrey M. Farma, Erwin Schultz, Sergi Vidal‐Sicart, Richard Hoefer, James M. Lewis, Randall P. Scheri, Mark C. Kelley, Omgo E. Nieweg, R. Dirk Noyes, Dave S.�B. Hoon, He-Jing Wang, David Elashoff, Robert M. Elashoff
Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma
Sapna P. Patel, Megan Othus, Yuanbin Chen, G. Paul Wright, Kathleen J. Yost, John Hyngstrom, Siwen Hu‐Lieskovan, Christopher D. Lao, Leslie A. Fecher, Thach‐Giao Truong, Jennifer L. Eisenstein, Sunandana Chandra, Jeffrey A. Sosman, Kari Kendra, Richard C. Wu, Craig Devoe, Gary B. Deutsch, Aparna Hegde, Maya Khalil, Ankit Mangla, Amy M. Reese, Merrick I. Ross, Andrew Poklepovic, Giao Q. Phan, Adedayo A. Onitilo, Demet G. Yasar, Benjamin Powers, Gary C. Doolittle, Gino K. In, Niels Kokot, Geoffrey T. Gibney, Michael B. Atkins, Montaser Shaheen, James Warneke, Alexandra P. Ikeguchi, Jose Eugenio Najera, Bartosz Chmielowski, Joseph G. Crompton, Justin D. Floyd, Eddy C. Hsueh, Kim Margolin, Warren Chow, Kenneth F. Grossmann, Eliana Dietrich, Víctor G. Prieto, Michael Lowe, Elizabeth I. Buchbinder, John M. Kirkwood, Larissa A. Korde, James Moon, Elad Sharon, Vernon K. Sondak, Antoni Ribas
Pancreatic Cancer: A Review of Current Treatment and Novel Therapies
Hordur M. Kolbeinsson, Sreenivasa R Chandana, G. Paul Wright, Mathew H. Chung
Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram
Amy C. Degnim, Carol Reynolds, Gouri Pantvaidya, Shaheen Zakaria, Tanya L. Hoskin, Sunni A. Barnes, Margaret V. Roberts, Peter C. Lucas, Kevin Oh, Meryem M. Koker, Michael S. Sabel, Lisa A. Newman
Is there truly an oncologic indication for interval appendectomy?
G. Paul Wright, Megan E. Mater, Joseph T. Carroll, Jennifer S. Choy, Mathew H. Chung
How much of the research on Michigan Cancer Research Consortium is open access?
ScholarIQopen access share
25%OPEN ACCESS